These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34672377)

  • 21. Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.
    Gorenshtein A; Liba T; Leibovitch L; Stern S; Stern Y
    Neurol Sci; 2024 Jul; 45(7):2951-2968. PubMed ID: 38695969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
    Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC;
    medRxiv; 2023 Jan; ():. PubMed ID: 36711478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: from an acute to chronic disease? Potential long-term health consequences.
    Higgins V; Sohaei D; Diamandis EP; Prassas I
    Crit Rev Clin Lab Sci; 2021 Aug; 58(5):297-310. PubMed ID: 33347790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
    Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
    Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
    Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
    Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'I can't cope with multiple inputs': a qualitative study of the lived experience of 'brain fog' after COVID-19.
    Callan C; Ladds E; Husain L; Pattinson K; Greenhalgh T
    BMJ Open; 2022 Feb; 12(2):e056366. PubMed ID: 35149572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19.
    Ishikura T; Nakano T; Kitano T; Tokuda T; Sumi-Akamaru H; Naka T
    Sci Rep; 2023 Aug; 13(1):13095. PubMed ID: 37567939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible Application of Melatonin in Long COVID.
    Cardinali DP; Brown GM; Pandi-Perumal SR
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From 'mental fog' to post-acute COVID-19 syndrome's executive function alteration: Implications for clinical approach.
    Pallanti S; Di Ponzio M; Gavazzi G; Gasic G; Besteher B; Heller C; Kikinis R; Makris N; Kikinis Z
    J Psychiatr Res; 2023 Nov; 167():10-15. PubMed ID: 37804756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID fog demystified.
    Kao J; Frankland PW
    Cell; 2022 Jul; 185(14):2391-2393. PubMed ID: 35768007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
    Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
    JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
    Stefano GB
    Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 in patients with Down syndrome.
    Emami A; Javanmardi F; Akbari A; Asadi-Pooya AA
    Neurol Sci; 2021 May; 42(5):1649-1652. PubMed ID: 33523318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and age affect acute and persisting COVID-19 illness.
    Vasilevskaya A; Mushtaque A; Tsang MY; Alwazan B; Herridge M; Cheung AM; Tartaglia MC
    Sci Rep; 2023 Apr; 13(1):6029. PubMed ID: 37055492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-dependent characteristics of Neuro-Long-COVID: Data from a dedicated neurology ambulatory service.
    Michelutti M; Furlanis G; Buoite Stella A; Bellavita G; Frezza N; Torresin G; Ajčević M; Manganotti P
    J Neurol Sci; 2022 Oct; 441():120355. PubMed ID: 35994869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.